ABBOTT LABORATORIES Total Liabilities 2007-2026 | ABT
Beta
What is total liabilities?
Total liabilities can be defined as the sum of all current and non-current debts and obligations owed by the company.
What is ABBOTT LABORATORIES's current total liabilities?
ABBOTT LABORATORIES (ABT) annual total liabilities for 2025 was $34.58B, a 2.47% increase from 2024. ABBOTT LABORATORIES total liabilities for the quarter ending March 31, 2026 was $58.37B.
What was ABBOTT LABORATORIES's total liabilities in 2024?
ABBOTT LABORATORIES annual total liabilities for 2024 was $33.75B, a 2.49% decline from 2023.
What was ABBOTT LABORATORIES's total liabilities in 2023?
ABBOTT LABORATORIES annual total liabilities for 2023 was $34.61B, a 8.32% decline from 2022.
What is ABBOTT LABORATORIES's 5-year total liabilities CAGR?
ABBOTT LABORATORIES total liabilities grew at a compound annual growth rate (CAGR) of 2.75% from FY2020 to FY2025, going from $39.76B to $34.58B over 5 years.
Total Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-2.8%
FY2020
$39.76B
→
FY2025
$34.58B
07080910111213141516171819202122232425
5 years selected
Total Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $34.58B | +2.5% | 10-K |
| FY2024 | $33.75B | -2.5% | 10-K |
| FY2023 | $34.61B | -8.3% | 10-K |
| FY2022 | $37.75B | -4.2% | 10-K |
| FY2021 | $39.39B | -0.9% | 10-K |
| FY2020 | $39.76B | +8.1% | 10-K |
| FY2019 | $36.80B | +0.4% | 10-K |
| FY2018 | $36.65B | -19.2% | 10-K |
| FY2017 | $45.35B | +41.2% | 10-K |
| FY2016 | $32.13B | +60.4% | 10-K |
| FY2015 | $20.04B | +1.8% | 10-K |
| FY2014 | $19.68B | +10.8% | 10-K |
| FY2013 | $17.77B | -56.1% | 10-K |
| FY2012 | $40.51B | +13.1% | 10-K |
| FY2011 | $35.84B | -5.4% | 10-K |
| FY2010 | $37.90B | +28.7% | 10-K |
| FY2009 | $29.44B | +18.0% | 10-K |
| FY2008 | $24.94B | +13.9% | 10-K |
| FY2007 | $21.89B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →